12-49950772-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The ENST00000199280.4(AQP2):c.-59G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00127 in 1,579,204 control chromosomes in the GnomAD database, including 20 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0069 ( 11 hom., cov: 33)
Exomes 𝑓: 0.00068 ( 9 hom. )
Consequence
AQP2
ENST00000199280.4 5_prime_UTR
ENST00000199280.4 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.433
Genes affected
AQP2 (HGNC:634): (aquaporin 2) This gene encodes a water channel protein located in the kidney collecting tubule. It belongs to the MIP/aquaporin family, some members of which are clustered together on chromosome 12q13. Mutations in this gene have been linked to autosomal dominant and recessive forms of nephrogenic diabetes insipidus. [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 12-49950772-G-A is Benign according to our data. Variant chr12-49950772-G-A is described in ClinVar as [Benign]. Clinvar id is 882310.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00686 (1045/152352) while in subpopulation AFR AF= 0.0231 (962/41582). AF 95% confidence interval is 0.0219. There are 11 homozygotes in gnomad4. There are 502 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 11 AD,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AQP2 | NM_000486.6 | c.-59G>A | 5_prime_UTR_variant | 1/4 | ENST00000199280.4 | NP_000477.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AQP2 | ENST00000199280.4 | c.-59G>A | 5_prime_UTR_variant | 1/4 | 1 | NM_000486.6 | ENSP00000199280 | P1 | ||
AQP2 | ENST00000550862.1 | c.-59G>A | 5_prime_UTR_variant | 1/3 | 5 | ENSP00000450022 | ||||
AQP2 | ENST00000551526.5 | c.-59G>A | 5_prime_UTR_variant, NMD_transcript_variant | 1/6 | 5 | ENSP00000447148 |
Frequencies
GnomAD3 genomes AF: 0.00684 AC: 1042AN: 152234Hom.: 12 Cov.: 33
GnomAD3 genomes
AF:
AC:
1042
AN:
152234
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000677 AC: 966AN: 1426852Hom.: 9 Cov.: 30 AF XY: 0.000573 AC XY: 404AN XY: 705082
GnomAD4 exome
AF:
AC:
966
AN:
1426852
Hom.:
Cov.:
30
AF XY:
AC XY:
404
AN XY:
705082
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00686 AC: 1045AN: 152352Hom.: 11 Cov.: 33 AF XY: 0.00674 AC XY: 502AN XY: 74508
GnomAD4 genome
AF:
AC:
1045
AN:
152352
Hom.:
Cov.:
33
AF XY:
AC XY:
502
AN XY:
74508
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Diabetes insipidus, nephrogenic, autosomal Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at